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Women exposed to diethylstilbestrol (DES) in utero frequently develop vaginal adenosis, from which
clear cell adenocarcinoma can arise. Despite decades of extensive investigation, the molecular
pathogenesis of DES-associated vaginal adenosis remains elusive. Here we report that DES induces
vaginal adenosis by inhibiting the BMP4/Activin A-regulated vaginal cell fate decision through a
downregulation of RUNX1. BMP4 and Activin A produced by vaginal mesenchyme synergistically
activated the expression of ΔNp63, thus deciding vaginal epithelial cell fate in the Müllerian duct
epithelial cells (MDECs) via direct binding of SMADs on the highly conserved 5′ sequence of ΔNp63.
Therefore, mice in which Smad4was deleted in MDECs failed to express ΔNp63 in vaginal epithelium and
developed adenosis. This SMAD-dependent ΔNp63 activation required RUNX1, a binding partner of
SMADs. Conditional deletion of Runx1 in the MDECs induced adenosis in the cranial portion of vagina,
which mimicked the effect of developmental DES-exposure. Furthermore, neonatal DES exposure
downregulated RUNX1 in the fornix of the vagina, where DES-associated adenosis is frequently found.
This observation strongly suggests that the downregulation of RUNX1 is the cause of vaginal adenosis.
However, once cell fate was determined, the BMP/Activin-SMAD/RUNX1 signaling pathway became
dispensable for the maintenance of ΔNp63 expression in vaginal epithelium. Instead, the activity of the
ΔNp63 locus in vaginal epithelium was maintained by a ΔNp63-dependent mechanism. This is the ﬁrst
demonstration of a molecular mechanism through which developmental chemical exposure causes
precancerous lesions by altering cell fate.
& 2013 Elsevier Inc. All rights reserved.Introduction
Diethylstilbestrol (DES) is a non-steroidal estrogen that was
administered to pregnant women from the 1940s to the 1970s
mainly for the prevention of miscarriages (FDA, 1972; Smith, 1948).
It has been estimated that as many as 90% of women exposed to
DES in utero develop cervical and vaginal adenoses, compared to
less than 4% in the general population (Antonioli and Burke, 1975;
Bibbo et al., 1975; Herbst et al., 1975; Johnson et al., 1979; Kaufman
et al., 1977; Ng et al., 1975; O'Brien et al., 1979). Adenosis of thell rights reserved.
117, Chicago, IL 60611, Unitedcervix and vagina is deﬁned as the presence of columnar cells
within the stratiﬁed squamous epithelium of the ectocervix and
vagina, and is considered as a congenital anomaly that arises via a
disruption of normal development. Vaginal adenosis itself is
benign, but is believed to be a precursor of vaginal clear cell
adenocarcinoma, which is 40 times more likely to occur in women
exposed to DES in utero (DES daughters) (Hoover et al., 2011;
Troisi et al., 2007). For this reason, the pathogenesis of DES-
associated vaginal adenosis has been an important issue of public
health. However, despite decades of extensive research, the
molecular mechanism underlying the development of DES-
associated vaginal adenosis remains elusive.
The epithelium of the female reproductive tract, including the
uterus, cervix and vagina develops from columnar epithelium of
the Müllerian duct (MD) (Kurita, 2010). As the MDs differentiate
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epithelial cells (MDECs) are induced to express organ speciﬁc
phenotypes by factors secreted from adjacent mesenchyme
(Boutin et al., 1991; Cunha, 1976; Kurita et al., 2001a). For example,
at birth, epithelial cells in the mouse uterus and vagina are mostly
undifferentiated (Kurita et al., 2001a), and uterine and vaginal
mesenchyme can program the epithelium of the neonatal uterus
and vagina to differentiate into specialized uterine and vaginal
epithelia, respectively. In mice, the developmental plasticity of the
MDECs is gradually lost around postnatal day 5 (P5) and thereafter.
Accordingly, epithelial cells from adult uterus and vagina cannot
be reprogrammed by factors secreted from vaginal or uterine
mesenchyme (Cunha, 1976; Kurita et al., 2001a, 2004). The
molecular nature of the mesenchymal factors that induce stratiﬁed
squamous differentiation of MDECs in the vagina and the down-
stream signaling pathways that mediate cell fate decision are yet
to be determined.
The transformation related protein 63 gene (Trp63/TP63 in mouse/
humans), an ortholog of the transformation related protein p53
(Trp53/TP53), plays a critical role in the cell fate decision of vaginal
epithelium (Kurita et al., 2004). Trp63 can be transcribed from
two distinct promoters generating two isoforms with alternative
N-terminal sequences, the transactivating (TA) and the N-terminally
truncated (ΔN) p63 (Yang et al., 1998). Its essential role in the
formation of stratiﬁed squamous epithelium was clearly demon-
strated by the phenotypes of Trp63 null mice, which completely
lacked stratiﬁed squamous epithelium (Mills et al., 1999; Yang et al.,
1999). In the vagina, Trp63 controls not only stratiﬁed squamous
differentiation but also determines vaginal epithelial identity, thus
allowing full expression of the various differentiation states char-
acteristic of vaginal epithelium (e.g. corniﬁcation and muciﬁcation).
Prior to squamous differentiation, undifferentiated MDECs express
p63, and p63 determines the cell fate of MDECs to be vaginal
epithelium. Hence, Trp63 null vaginal epithelium differentiates into
simple columnar uterine epithelium within the vagina (Kurita et al.,
2004). We have also demonstrated that DES action via ERα induces
vaginal adenosis by blocking the p63 induction in MDECs (Kurita
et al., 2004). However, the molecular mechanism of Trp63 induction
as well as the mechanism through which DES/ ERα disrupts this
process is unknown.
In our current study, we demonstrated that the differentiation
program of vaginal epithelium is regulated by ΔNp63. Hence, we
investigated the molecular mechanism that controls ΔNp63
expression in MDECs. This report demonstrates that two trans-
forming growth factor β (TGFβ) family ligands, activin A (ActA) and
bone morphogenetic protein 4 (BMP4), induce the vaginal epithe-
lial cell fate in undifferentiated MDECs via an activation of the
ΔNp63 locus; that SMAD4 and RUNX1 are essential to mediate the
action of ActA and BMP4 in the activation of ΔNp63; and that DES
inhibits ΔNp63 expression and vaginal differentiation in MDECs by
reducing RUNX1 expression. Furthermore, we demonstrate that
the BMP4/ActA-SMAD/RUNX1 signaling pathway is required for
activation of ΔNp63 locus but not for the maintenance of ΔNp63
expression in the vaginal epithelium. Data presented in this study
describes the molecular mechanism through which MDECs are
specialized to become vaginal epithelium, and by doing so, this
study gives the ﬁrst insight on how in utero DES exposure causes
pre-malignant lesions in the female genital tract.Materials and methods
Mouse models
All procedures involving mice were approved by the North-
western University Animal Care and Use Committee. The followingmice were used in this study: Trp63ﬂoxN (Mills et al., 2002), ΔNp63-
EGFP knock-in (Trp63 ΔNp63-EGFP-KI) (Romano et al., 2012), Wnt7a-
Cre (Winuthayanon et al., 2010), Smad4ﬂox (Yang et al., 2002), Pax2-
Cre (MMRRC) (Ohyama and Groves, 2004), Pax8-rtTA (Traykova-
Brauch et al., 2008), tetO-cre (Perl et al., 2002), RosaTE [Gt(ROSA)26Sortm4
(ACTB-tdTomato,–EGFP)Luo/J] (Muzumdar et al., 2007), Runx1ﬂox (Taniuchi
et al., 2002), NSG (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ), C56BL/6 (Jackson
Laboratory, Bar Harbor, ME, USA), CD-1 (Charles River Laboratories,
Roanoke, IL, USA). Lines originally in the mixed genetic background
were crossed to wild-type C57BL/6J at least 3 times before experi-
ments. All Cre strains were maintained by breeding with C57BL/6J.
With some exceptions, conditional knockout lines were crossed with
the RosaTE to verify appropriate Cre expression.
Drug treatments
Dorsomorphin: Dorsomorphin (Sigma-Aldrich, St. Louis, MO,
USA), a kinase inhibitor of type I receptors for BMPs (ALK2,
3 and 6), was dissolved in dimethyl sulfoxide (DMSO) (Life
Technologies, Carlsbad, CA, USA) at 10 mg/ml and mixed with
peanut oil (Sigma-Aldrich) to 1 mg/ml before injection. The ﬁrst
injection started within 8 h after birth, and newborn mice received
two daily injections of 5 mg/kg (5 ml/kg) dorsomorphin subcuta-
neously for 5 days (N¼6). The control group (N¼5) received the
equal amount of DMSO+peanut oil, and the DES group (N¼6), the
positive control for ΔNp63 disruption, received 1 mg/kg DES in the
same vehicle subcutaneously in the same schedule. Doxycycline
(DOX): Mice were fed with water containing 500 mg/ml doxycy-
cline hydrochloride hemiethanolate hemihydrate (Sigma-Aldrich)
and librium. 17β-Estradiol: Six-months-old cKO mice received daily
i.p. injection of 100 ng 17β-estradiol for 3 days. Diethylstilbestrol
(DES): A 100 mg DES slow-release pellet was prepared as follows.
Silastic tubing (Dow Corning, Elizabethtown, KY, USA) ﬁlled with
DES powder (Sigma-Aldrich) at ∼0.04 mg/mm was prepared by
ﬁlling the tubing with 10 mg/ml DES solution in ethanol and
allowing ethanol to evaporate through the wall of the tubing. The
DES ﬁlled tubing was cut into 2.5 mm length and subcutaneously
injected into newborn mice. As assessed by the degree of ΔNp63
repression at P3-5, the Silastic pellet technique was more effective
and consistent than the standard protocol with daily injections of
5 mg DES in 20 ml peanut oil (Forsberg, 1972; Newbold and
McLachlan, 1982; Plapinger and Bern, 1979).
Microarray
Total RNA was extracted from the vaginae of P2 Trp63 cHet and
cKO, and uteri of P2 Trp63 cHet females. Twelve samples (3 groups
of 4 replicates each taken from 4 to 6 mice) were hybridized to two
Illumina MouseWG-6 version2 slides. The array data were average
normalized (GSE44697), and then further analyzed at the Genomic
Core at Northwestern University (Table S1).
Hanging droplet culture of uterine piece
Uterine horns dissected from P1 mice were cleaned in cold
DMEM/Hams F-12 50:50 medium supplemented with antibiotic-
antimycotic (Life Technologies). Each uterine horn was cut into
3 pieces. Then, each piece was placed in the top of 100 ml PCR tube,
and the PCR tube top was ﬁlled with 80 ml of serum free culture
medium (DMEM/Hams F-12 50:50 medium with Insulin-
Transferrin-Selenium-G Supplement) (Life Technologies) contain-
ing 0.1 or 0.2 mg/ml recombinant mouse BMP4 and/or Activin A
(R&D system, Minneapolis, MN, USA). The tube-tops containing
the uterine piece and medium were placed on a 96 well plate to
cover wells. The wells were ﬁlled with the culture medium to
maintain the humidity, the plate was covered with the lid, placed
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medium changes. After 4 days, uterine pieces were ﬁxed and
processed for histological analysis.
Immunostaining
Tissue collected for immunohistochemistry was ﬁxed in 4%
paraformaldehyde or Modiﬁed Davidson's ﬁxative solution (Elec-
tron Microscopy Sciences, Hatﬁeld, PA, USA) overnight. Tissue was
processed, embedded in parafﬁn and sectioned at 5 mm. Slides
were deparafﬁnized by soaking into pre-warmed 1.3% Palmolive
Ultra Original Concentrated (Colgate, New York, NY, USA),
immersed into antigen-retrieval buffer (10 mM Sodium Citrate,
0.05% Tween-20, pH 6.0) and heated in the Deni Electric Pressure
Cooker (Keystone Manufacturing Co, Buffalo, NY, USA) for 45 min.
For the detection of both ΔN and TAp63 isoforms (labeled as p63
in ﬁgures), anti-p63 mouse IgG (clone 4A4) (1:100, Santa Cruz
Biotechnology, Santa Cruz, CA, USA) was used. In addition, the
following primary antibodies were used at the indicated concen-
tration: anti-ΔNp63 (PC373) (1:2000); anti-pSMAD2/3 (anti-
pSMAD2, cross reacts with pSMAD3) (1:400, Millipore, Billerica,
MA, USA); anti-Cytokeratin 14 (LL001, 1:50), anti-GFP (1:100),
(Santa Cruz Biotechnology); anti-p(S463/465) SMAD1/5/8
(1:100, Cell Signaling Technology, Danvers, MA, USA); anti-PR
(1:100, DAKO); anti-RUNX1 (1:100, Epitomics, Burlingame, CA,
USA); anti-SMAD4 (1:25); anti-Ki-67/MKI67 (1:100, Abcam, Cam-
bridge, MA, USA); anti-ERα (1:100, Lab Vision Co., Fremont, CA,
USA). Secondary antibodies (AlexaFluor594-anti-mouse IgG,
AlexaFluor488-anti-rabbit IgG, and biotinylated anti-mouse or
anti-rabbit IgG) and Streptavidin-HRP were purchased from Jack-
son ImmunoResearch (West Grove, PA, USA). Micrographs were
captured using a BZ-9000 microscope (Keyence, Itasca, IL, USA).
Images were captured on the same day using the same exposure
settings. The quantitative analysis on the squamous transforma-
tion of uterine epithelium was performed on immunostained
slides for K14 using ImageJ (NIH, MD, USA) as previously reported
(Kurita et al., 2001b). Brieﬂy, all images were captured under the
same lighting conditions. The epithelial areas were manually
selected from the images. Then, K14-positive epithelial areas
were selected in the combination of yellow and black channels
in CMYK mode as the area with optical density higher than
that of the negative control. The ratio of squamous epithelial area
was calculated by dividing the K14-positive area by the total
epithelial area.
5′ Rapid ampliﬁcation of cDNA ends (5′ RACE)
Vaginal epithelium was collected from 10 P21 CD-1 mice as
previously described (Kurita et al., 2001a). 5′ RACE of separated
vaginal epithelium was performed using the GeneRacer Kit (Life
Technologies) by following the manufacturer's instructions. The
following primers were used: p63 reverse GACCAGCACGCTCTG
CCTTCCCGTGATA; p63 nested reverse AGTACAGCTTCTTCAGTTC
GGTGGAATA.
Chromatin immunoprecipitation (ChIP) assay
Epithelia isolated from P1.5-3 C57BL/6J mice were ﬁxed in
DMEM with 27 ml/ml of 37% formaldehyde at 37 1C for 10 min.
Pelleted samples were ﬂash frozen and stored at 80 1C. Samples
were thawed in 400 ml of 50 mM Tris–HCl pH 8.0, 10 mM EDTA,
10% SDS with a proteinase inhibitor cocktail (Millipore), digested
using 20 units of Micrococcal Nuclease (New England Biolabs,
Ipswich, MA, USA) at 37 1C for 10 min. Samples were diluted to
2 mg/ml DNA with ChIP Dilution Buffer (Millipore) and rotated at
4 1C overnight with anti-SMAD4 (Santa Cruz Biotechnology) orRabbit IgG overnight. For the visualization of PCR products on
electrophoresis gels, anti-histone H3 rabbit IgG (Abcam) was used
as the positive control for immunoprecipitation. The protein-
chromatin complexes were isolated by Dynabeads (Life Technol-
ogies). A 10% Chelex 100 bead (BioRad, Des Plaines, IL, USA)
solution was added and boiled for 10 min. The samples were
treated with proteinase K for 30 min at 55 1C and boiled again for
10 min. DNA was eluted into ∼100 ml H2O. Real-time PCR was
performed on an ABI Prism 7000 using Power SYBR Green PCR
mastermix (Life Technologies) with the following primers:
Forward; AGAGTGCACTTTCTTATGAAAGAGA; Reverse CCCAAACA-
AACCTACCACCC.
Subrenal capsule grafting
The procedure for subrenal grafting of mouse embryonic
vaginae has been described previously (Kurita et al., 2004). Brieﬂy,
dissected embryonic vaginae were transplanted under the sub-
renal capsule of adult females NSG mice. Two weeks after grafting,
grafts on kidney were collected, photographed under the Zeiss
Discovery dissecting microscope with ﬂuorescence, ﬁxed and
processed for histological analyses.
Immunoblotting analysis
Approximately one third of the cranial portion of the vaginae
from P3 mice with DES or control pellets were homogenized in
lysis buffer with a protease inhibitor cocktail (Roche, Indianapolis,
IN, USA). Proteins from 2 vaginae were run per well with
4 replicates for each group. Standard Western blot protocol was
performed with ECL Prime Blocking and Prime Western Blotting
Detection agents (GE Healthcare Biosciences, Pittsburgh, PA, USA).
Since DES reduces the epithelial proliferation rate, the relative
yield of epithelial tissue within the vagina was expectedly reduced.
Therefore, the level of RUNX1 was normalized to E-cadherin, an
epithelial marker. After detection with anti-RUNX1 antibody
(1:5000), blots were stripped and reprobed with anti-E-cadherin
antibody (1:10,000, Abcam). Chemiluminescence signal was
detected and quantiﬁed using the FluorChem HD2 System (Pro-
teinsimple, Santa Clara, CA, USA).Results
ΔNp63 is required for vaginal epithelial cell fate decision Müllerian
duct epithelial cells (MDECs)
To conﬁrm the essential role of Trp63 in the vaginal epithelial
cell fate decision, Trp63 was conditionally deleted in MDECs by
crossing Trp63ﬂoxN/ﬂoxN (Mills et al., 2002) and Pax2-Cre (Kurita,
2010; Ohyama and Groves, 2004) mice. Female Trp63ﬂoxN/ﬂoxN;
Pax2-Cre+ (Trp63 conditional knockout, cKO) mice demonstrated
extensive surface adenoses (Johnson et al., 1979) in the cervix and
vagina (Fig. 1A and B). Gland-like structures of occult adenoses
were also detected focally in fully mature female cKO mice. The
vaginal epithelia of Trp63 cKO mice did not express cytokeratin 14
(K14), a marker for squamous epithelial cells (Fig. 1A), but
expressed progesterone receptor (PR) in the absence of estrogen
(Fig. 1B), which is a unique marker for murine uterine epithelium
(Kurita et al., 2000). When the adult Trp63 cKO mice were treated
with estradiol, the occult adenosis became easily detectable in
H&E stained sections (Fig. 1C, arrows). The phenotypes of Trp63
cKO conﬁrmed the critical role of Trp63 in the cell fate decision to
be vaginal or uterine epithelium.
To identify the promoter of Trp63 in vaginal epithelium, 5′ RACE
analysis was performed on P21 vaginal epithelium and generated
Fig. 1. ΔN63 is required for commitment of MEDCs to vaginal epithelial cell fate. (A) Immunohistochemical detection of K14 squamous differentiation markers in the vagina of adult
Trp63 cHet and cKO mice (P60). While cHet vaginal epithelium demonstrated stratiﬁed squamous differentiation with the expression of K14, vaginal epithelial cells in cKO remained
simple columnar and K14-negative. The gland-like structures are outlined. (B) Uterine epithelial differentiation marker (PR). Trp63 cHet and cKO females were ovariectomized (OVX) at
age of 8 weeks, and the expression of PR was analyzed 2 weeks later. Due to the absence of ovarian steroids, vaginal epithelium became thin in both ovariectomized cHet and cKO
mice. The expression of PR in the absence of estrogen indicates uterine epithelial differentiation of MDECs in the cKO vagina. (C) Adenosis lesion in 6 month-old Trp63 cKO vagina
(H&E). Adult female mice (6-month-old) were given 17β-estradiol 100 ng/day for 3 days to demonstrate the absence of squamous epithelial cells in the fornix. The fornix was
completely lined by columnar epithelium (surface adenosis), and gland-like structures of occult adenosis were often found (arrows). (D) Strategy for conditional ablation of ΔNp63 in
MDECs. The ΔNp63 cKOmice carry a copy of the Trp63ﬂoxN allele and the ΔNp63-EGFP knock-in allele. Activation of Cre generates a null allele for the ﬂoxed allele, thus TAp63 from the
ΔNp63-EGFP knock-in allele is the only p63 protein expressed in MDECs. (E) Body weight of ΔNp63 Het and cKO female mice at P14. The body weight of female ΔNp63 cKOmice was
signiﬁcantly lower than that of ΔNp63 Het (Student's t-test, *p¼0.006). Bars indicate average7SD. (F) Immunodetection of K14 and PR in the vaginal fornix of P14 ΔNp63 Het and cKO
mice. The ΔNp63 protein (green) was detected in a subset of epithelial cells within the vagina of ΔNp63 cKO (arrows), indicating an incomplete gene deletion. These ΔNp63 positive
cells were also positive for K14 (red), indicating normal vaginal differentiation. The K14-negative vaginal epithelial cells in ΔNp63 cKO mice expressed PR at P14. Thus, the cell fate of
MDECs to be vaginal or uterine epithelium is deﬁned by the presence or absence of ΔNp63 expression. Bar¼50 mm.
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verifying the predominant expression of ΔNp63 in vaginal epithe-
lium as we previously reported (Kim et al., 2013; Kurita et al.,
2005). To assess the necessity of ΔNp63 in vaginal epithelial
differentiation, we generated ΔNp63 cKO mice (Fig. 1D) (KimFig. 2. BMP4 and Activin A instruct MDECs to express ΔNp63. (A) Quantitative RT-PCR
(M) of P2 uteri (Ut) and vaginae (Vg). In addition to Bmp4 and Inhba, Gdf10 was also signi
*po0.05 (Student's t-test) for the comparisons indicated by the brackets. (B) Immuno
(pSMAD1/5/8) and activin A-activated (pSMAD2/3) R-Smads (green). DAPI (blue), p63 (re
cells, pSMAD1/5/8 was detected only in a small subset of vaginal epithelial cells (arrow
bar¼20 mm). (C) Dorsomorphin treatment inhibited expression of ΔNp63 in MDECs. Do
continuous layer of ΔNp63 (green)-positive basal cells formed throughout the vagina
groups contained only a small number of ΔNp63 positive cells by P6. As assessed by proli
BMP4 and ActA transformed uterine epithelium into vaginal epithelium. The treatment w
epithelium as indicated by expression of p63 and K14. In contrast, 0.2 mg/ml ActA alone
enhanced the effect of BMP4, and 0.1 mg/ml BMP4+0.1 mg/ml ActA treatment induce
Quantitative analysis on the degree of squamous transformation. Uterine explants incu
analysis. The ratio of K14 positive area was signiﬁcantly higher in 0.2 mg/ml BMP4 group
In addition, degree of squamous differentiation was higher in the 0.1 mg/ml ActA+0.1 mget al., 2013). While Trp63 cKO mice demonstrated no health
problems, ΔNp63 cKO mice were signiﬁcantly smaller than het-
erozygous control (Fig. 1E) and often die before weaning. Since
Pax2-Cre was active in multiple tissues including the kidney,
endothelium, and brain, the loss of balance between TA and ΔNanalysis for TGFβ family ligands on the separated epithelium (E) and mesenchyme
ﬁcantly higher in the VgM than the UtM. Bars indicate average number7SD (N¼4).
ﬂuorescent analysis of P3 vagina and uteri for phosphorylation of BMP-activated
d). While pSMAD2/3 was uniformly expressed in both uterine and vaginal epithelial
s). These pSMAD1/5/8 positive cells co-expressed a minimum level of p63 (insert,
tted lines indicate the boundary between epithelium and mesenchyme. Whereas a
in the DMSO control group, the vaginal fornix of dorsomorphin- and DES-treated
feration marker Ki-67 (red), dorsomorphin did not affect epithelial proliferation. (D)
ith 0.2 mg/ml BMP4 alone focally induced the squamous transformation of uterine
had no or minimum effect on the uterine epithelium. However, ActA synergistically
d p63/K14 positive squamous cells throughout the epithelium. Bar¼50 mm. (E)
bated with 0.1 mg/ml ActA were negative for K14 and p63, thus excluded from the
than control, 0.2 mg/ml ActA and 0.1 mg/ml BMP4 groups (Students' t-test, po0.05).
/ml BMP4 group than any other groups (Student's t-test, ***po0.0001).
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The vagina of ΔNp63 cKO mice appeared to be underdeveloped
and frequently demonstrated the expression of ΔNp63/K14 due to
incomplete gene deletion (Fig. 1F, arrows). In addition, the ΔNp63
cKO mice died before they reached the appropriate age to develop
the occult adenosis. Nonetheless, as assessed at P14, ΔNp63 null
vaginal epithelium showed identical phenotypes to that of Trp63
cKO mice, such as expressing differentiation markers for uterine
epithelium (Fig. 1F, PR). These observations conﬁrmed that the
presence and the absence of ΔNp63 expression determine the cell
fate of MDECs within the vagina to become vaginal (presence) or
uterine (absence) epithelium.
BMP4 and Activin A synergically activate ΔNp63 and induce vaginal
epithelial cell fate in MDECs
To identify the mesenchymal factors that induce ΔNp63 in
MDECs, we performed a microarray analysis on the uterus and
vagina isolated from postnatal day 2 (P2) Trp63 cKO and cHet mice.
Differential gene expression between vaginal and uterine tissues
should reﬂect both the upstream and downstream of Trp63
expression, whereas the comparison between cKO and cHet
vaginae should identify what is downstream of Trp63 as differ-
ences. Thus, the three-way comparison should identify what is
upstream of Trp63. By this method two TGFβ family ligands were
identiﬁed: bone morphogenetic protein 4 (Bmp4) and inhibin βA
(Inhba) as potentially upstream of ΔNp63 (Table S1), while the
levels of SMADs and receptors for TGFβ family ligands were similar
in both uterus and vagina (Fig. S2). The expression levels of TGFβ
family ligands (Bmp3, Bmp4, Bmp7, Gdf10, Tgfb2, Tgfb3 and Inhba),
which were positively detected by microarray in either the uterus
or vagina, were further examined by quantitative RT-PCR using
mRNA extracted from epithelium and mesenchyme of P2 uteri and
vaginae (Fig. 2A). Bmp4 and Inhba, the activin A (ActA) subunit,
were more robustly expressed in vaginal compared to the uterine
mesenchyme. Although the expression level of Gdf10 was signiﬁ-
cantly higher in vaginal than uterine mesenchyme, the uterine
mesenchyme still expressed a substantial level of Gdf10, suggest-
ing that GDF10 does not induce vaginal epithelial differentiation.
In agreement with the expression pattern of ligands, receptor-
mediated phosphorylation of BMP-regulated SMADs (pSMAD1/5/
8) was detected only in vaginal epithelium (Fig. 2B, white arrows).
Interestingly, at P2-3, pSMAD1/5/8 was detected only in a small
subset of vaginal epithelial cells with a minimum level of p63
expression, indicating that BMP4 action occurs before activation of
the ΔNp63 locus. Unlike pSMAD1/5/8, activation of ActA-regulated
SMADs (pSMAD2/3) was uniformly detected in both uterine and
vaginal epithelia (Fig. 2B). Since GDF10 signaling is mediated by
SMAD2/3 (Miyazono et al., 2010), the activation of SMAD2/3 in the
uterus may reﬂect the activity of GDF10 produced by uterine
mesenchyme. The expression pattern of phospho-R-SMADs sug-
gested the critical role of BMP4 in the activation of the ΔNp63
locus in MDECs. This was further conﬁrmed as the injection of
neonatal mice with dorsomorphin, a kinase inhibitor of type I
receptors for BMPs (ALK2, 3 and 6) (Yu et al., 2008), inhibited the
induction of ΔNp63 in the vaginal epithelium. Whereas a contin-
uous layer of ΔNp63 positive cells formed in the cervix and vagina
of control mice (DMSO) by P6, P6 dorsomorphin treated mice
showed patches of ΔNp63-negative cells within the vaginal
epithelium (N¼6 each, Fig. 2C). However, the effect of BMP-
inhibitor was not identical to that of DES. Whereas DES inhibited
both the epithelial proliferation and the expression of ΔNp63,
inhibition of BMP signaling did not affect proliferation of vaginal
epithelium as assessed by Ki-67/MKI67 (Fig. 2C).
To test whether BMP4 and/or ActA can be substitutions for the
vaginal mesenchymal factors that activate the vaginal epithelialdifferentiation program in MDECs, uterine horns from P2 neonatal
mice were cultured with BMP4 and/or ActA (Fig. 2D). The uterine
epithelium in control medium maintained its simple columnar
morphology and expressed neither p63 nor K14, whereas those
treated with 0.2 mg/ml ActA showed a few cells that expressed p63
and K14 (Fig. 2D, arrow). BMP4 (0.2 mg/ml) exhibited a stronger
effect than ActA in initiating vaginal epithelial differentiation in
uterine epithelium as stratiﬁed layers of cells formed and more
basal cells expressed p63 and K14 than the ActA-treated group.
However, the most robust effect was observed when uterine
pieces were cultured with 0.1 mg/ml BMP4 plus 0.1 mg/ml ActA.
While each ligand alone exhibited minimum or no activity at this
concentration (Fig. 2E), BMP4 and ActA synergistically ampliﬁed
their activity to initiate the vaginal epithelial differentiation
process as the uterine epithelium clearly differentiated into K14-
positive stratiﬁed squamous epithelium with an extended p63-
positive basal cell layer. These results established that differential
expression of BMP4 and ActA between uterine and vaginal
mesenchyme is the factor that determines the epithelial cell fate
of MDECs in the uterus and vagina.BMP4 and ActA induce ΔNp63 expression via direct binding of SMADs
on the 5′ sequence of ΔNp63
The essential role of BMP in the induction of ΔNp63 in MDEC
was demonstrated by the dorsomorphin-treatment study (Fig. 2C).
However, dorsomorphin inhibits the kinase activity of type I
receptors for BMP, which can activate the SMAD-mediated tran-
scription as well as other kinase pathways, such as mitogen-
activated protein kinase. Thus, it was not clear if the BMP4 and
ActA induced the expression of ΔNp63 through SMAD mediated
signaling. ECR browser (Ovcharenko et al., 2004) and VISTA enhan-
cer browser (http://enhancer.lbl.gov/) identiﬁed a highly conserved
sequence on the 5′ region of ΔNp63 TSS. In silico analysis identiﬁed
multiple SMAD binding elements conserved between the human
and mouse within the region (Fig. S3). Furthermore, a SMAD5
binding element and SMAD3/4 binding sites within this sequence
showed similar conﬁgurations to the Bmp2b/Smad5 regulated
promoter of Zebraﬁsh ΔNp63 (Bakkers et al., 2002). Therefore, a
chromatin immunoprecipitation (ChIP) assay for SMAD4, the co-
SMAD required for transcriptional activities of both BMP-regulated
and Activin-regulated SMADs (Massague, 2012), was performed to
test whether SMADs bind to the conserved 5′ region of ΔNp63 in
vaginal and uterine epithelial cells isolated from P2-3 mice. By pull-
down using anti-SMAD4 antibody, the chromatin fragments con-
taining SMAD binding elements were signiﬁcantly enriched in the
vaginal epithelium in comparison to uterine epithelium (Fig. 3A,
*po 0.05). This agrees with our model in which BMP/Activin
signaling activates expression of ΔNp63 via binding of SMADs on
the 5′ proximal sequence of ΔNp63. Furthermore, the requirement
of SMAD4 in the activation of ΔNp63 locus was tested by generating
Smad4 cKOmice of MDECs. The Smad4ﬂox/ﬂox (Yang et al., 2002) mice
were crossed with Wnt7a-Cre+ (Winuthayanon et al., 2010) mice,
because the Smad4ﬂox/ﬂox; Pax2-Cre+ mice were embryonic lethal.
The vaginae of Smad4ﬂox/ﬂox; Wnt7a-Cre+ (Smad4 cKO) were lined
with ΔNp63- and K14- negative columnar epithelial cells (Fig. 3B).
In addition, Smad4 cKO vaginal epithelium expressed PR in the
absence of estrogen at P14, indicating uterine epithelial cell fate
(Fig. 3B).
In summary, BMP4 and ActA produced by vaginal mesenchyme
induce expression of ΔNp63, thus determining vaginal epithelial
cell fate in MDECs, via direct binding of SMADs on the Smad
binding elements within a highly conserved 5′ proximal sequence
of ΔNp63.
Fig. 3. Vaginal cell fate induction by BMP4 and ActA is mediated by SMADs/RUNX1. (A) ChIP assay on 5′ conserved sequence of ΔNp63 with anti-SMAD4 antibody (Fig. S3).
H3, anti-Histone H3 positive control. The fold change enrichment indicates a ratio of CT value of SMAD4 IP to that of rabbit IgG negative control. SMAD4 ChIP enriched the
putative ΔNp63 regulatory sequence in vaginal (VgE) than uterine (UtE) epithelium (*p¼0.02, Student's t-test). Bars indicate average number7SD (N¼4). (B) Expression of
vaginal and uterine epithelial markers in the vaginae of Smad4 cHet (control) and cKO mice. The boundary between epithelial and mesenchymal tissues is indicated with a
white dotted line. VgE of Smad 4 cKO mice failed to express ΔNp63 (green) and K14 (red) (P6, upper panels). Instead, MDECs differentiated into UtE within vagina, expressing
PR at P14 (brown). (C) RUNX1 expression in P3 vagina and uterus. At P3, RUNX1 (green) was highly expressed in VgE while UtE was mostly negative. Bar¼50 mm. (D) Vaginal
phenotypes of Runx1 cKO mice. The vaginal fornix of Runx1 cKO was totally negative for ΔNp63 (green) and K14 (red) at P7. However, the caudal portion of Runx1 cKO vagina
contained ΔNp63/K14 positive stratiﬁed squamous epithelial cells. Therefore, requirement of RUNX1 for MDECs to express ΔNp63 was region speciﬁc. (E) SMAD4 and RUNX1
did not regulate expression of each other. Immunoﬂuorescence assay for SMAD4 (green) and p63 (red) (the upper panels), and RUNX1 (green) (the lower panel) was
performed on P2 vaginae. All panels are arranged as the epithelium (ep) on the left and the mesenchyme (ms) on the right side. The boundary between two tissues is
indicated by a dotted line. At P2, wild-type vaginal tissues expressed SMAD4 in the epithelium and mesenchyme, and RUNX1 only in the epithelium. Vaginae of P2 Smad4
cKO mice expressed SMAD4 only in mesenchymal tissues, conﬁrming the success of the epithelial-speciﬁc gene knockout strategy. Likewise, Runx1 cKO vaginal epithelium
was totally negative for RUNX1. The expression of RUNX1 in Smad4 cKO as well as the expression of SMAD4 in Runx1 cKO was maintained. Bar¼50 mm.
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The microarray analysis identiﬁed Runt-related transcription
factor 1 (Runx1) as a gene highly present in vaginal tissues (Table
S1). Immunoﬂuorescence analysis agreed with this result; RUNX1
was more highly expressed in vaginal than uterine epithelium at
P3 (Fig. 3C). RUNX family members have been shown to work as
co-transcription factors in SMAD-mediated gene expression (Ito
and Miyazono, 2003), and the RUNX1 expression pattern (Fig. 3C)
strongly suggests an involvement of RUNX1 in the BMP4/ActA-
regulated cell fate decision in MDECs. To test whether RUNX1 isrequired for the activation of ΔNp63 in MDECs, Runx1 cKO
(Runx1ﬂox/ﬂox; Wnt7a-Cre+) mice were generated. Interestingly,
the requirement of RUNX1 in ΔNp63 activation showed a regional
speciﬁcity. In Runx1 cKO mice, the cranial-region of the vagina,
where DES-associated adenoses usually develop, was lined with
simple columnar cells that completely lacked expression of ΔNp63
and K14, establishing its essential role in vaginal epithelial
differentiation (Fig. 3D, cranial). In contrast, the caudal region of
vagina was lined with ΔNp63-positive squamous epithelium
(Fig. 3D, caudal). Although the epithelial phenotypes of the upper
vagina in Runx1 and Smad4 cKO mice were similar, the absence of
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mice still expressed RUNX1 in the vaginal epithelium, and Runx1
cKO mice expressed SMAD4 (Fig. 3E). Thus, the expression of
RUNX1 and SMAD4 is independently regulated, but both tran-
scription factors are essential for the activation of ΔNp63 in
vaginal epithelium.Fig. 4. DES alters vaginal epithelial cell fate through downregulation of RUNX1. (
Immunoﬂuorescence assay for phosphorylation of R-SMADs, SMAD4 and RUNX1 were p
of SMAD4 as well as phosphorylation levels of BMP-regulated SMADs (pSMAD1/5/8) and
VgE. In contrast, RUNX1 level was signiﬁcantly reduced by DES in the fornix (correspond
expression was strongest in the outer wall of fornix, in which DES-associated adenosis
maintained relatively high in the lip of cervix (indicated by arrows), where DES usually s
(C) Immunoblotting analyses of DES-effect on the RUNX1 level in the cranial portion of
DES) vaginae (*po0.02, Student's t-test). Bars indicate the average number7SD for the
cKO mice phenocopied neonatally DES-treated mice. Similar adenotic lesions negative fo
exposed (WT+DES) female mice at P40 (arrows). Bar¼50 mm.DES alters vaginal epithelial cell fate through downregulation of
RUNX1
We have previously shown that neonatal DES exposure pre-
ferentially blocks expression of p63 in the fornix of the vagina and
the common cervical canal in P5 mice, and these p63 negativeA) Effect of DES on BMP4/ActA-SMAD/RUNX1 signaling in the vaginal fornix.
erformed on vaginae of P3 control and DES-treated mice. At P3, overall expression
Activin-regulated SMADs (pSMAD2/3) were unchanged or increased by DES in the
ing to the area marked with a square in B). (B) The effect of DES on RUNX1 (green)
most often develops (marked with a square). In contrast, RUNX1 expression was
hows minimum effect on the expression of ΔNp63 (Kurita et al., 2004). Bar¼50 mm.
vagina at P3. The RUNX1 level was lower in the DES-treated (+DES) than control (–
relative signal intensity of RUNX1 over E-cadherin (E-CAD) (n¼4). (D) Adult Runx1
r p63/K14 were detected in the vaginal fornices of Runx1 cKO and neonatally DES-
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structures (Kurita et al., 2004). Thus, the disruption of the devel-
opmental signal by DES should be highly detected in the vaginal
fornix and the common cervical canal. In order to determine if and
at what level DES interrupts the BMP4/ActA-SMAD/RUNX1 signal-
ing pathway, immunoﬂuorescence analysis was performed focus-
ing on the signal alterations in the vaginal fornix at P2-3. First, the
effect of DES-exposure on the receptor-mediated phosphorylation
of R-SMADs was examined. The signals for receptor-mediated
phosphorylation of pSMAD2/3 showed minimum change
(Fig. 4A). Surprisingly, the signals for receptor-mediated phosphor-
ylation of pSMAD1/5/8 were higher in DES-treated than control
vaginal epithelium (Fig. 4A). Therefore, DES does not interfere with
the BMP4/ActA-SMAD/RUNX1 pathway at the upstream of R-
SMADs. Additionally, overall expression of SMAD4 within the
vaginal epithelium was unchanged with DES treatment (Fig. 4A).
In contrast, the expression pattern of RUNX1 showed a dramatic
change in response to DES-exposure, and the substantial number
of epithelial cells in the vaginal fornices became almost negative
for RUNX1 at P2-3 (Fig. 4A and B). Although RUNX1 was not
uniformly downregulated throughout the vaginal epithelium,
immunoblotting analysis of the upper vaginae detected a signiﬁ-
cant difference (*po0.05) in the level of RUNX1 between control
and DES-treated mice (Fig. 4C). Having an essential role in ΔNp63
expression as demonstrated by the cKO study, the downregulation
of RUNX1 in the fornix should block the BMP4/ActA action on the
ΔNp63 locus. We propose that DES induces vaginal adenosis by
inhibiting activation of vaginal epithelial cell fate via a down-
regulation of RUNX1. This model is further supported by a striking
phenotypic similarity between the vaginae of adult Runx1 cKO
mice and adult wild type mice that were neonatally exposed to
DES (Fig. 4D). In both Runx1 cKO and neonatally DES-exposed
mice, unaffected squamous epithelial cells in the caudal portion of
vagina grew upwards replacing the columnar epithelial cells in the
surface adenosis during development. Thus, in the adult female,
adenosis lesions remained mostly as the occult adenosis in the
vaginal fornix. The region-speciﬁc requirement of RUNX1 in the
activation of ΔNp63 may explain why adenosis occurs only in the
upper part of vagina.Fig. 5. BMP4/ActA-SMAD/RUNX1 signaling is dispensable for expression of ΔNp63 in di
cells in the vagina. At P6, basal cells with K14 expression (arrow) showed lower signals f
for expression of ΔNp63 in the adult VgE. In the vaginae of adult Runx1 cKO mice (P42)
indicates a rare RUNX1-positive cell. Furthermore, p63 (red) and EGFP for Cre-reporter
adult vaginal epithelium. (C) SMAD4 is dispensable for ΔNp63 expression in adult VgE.
(rtTA) is expressed in embryonic MDECs as well as MDEC-derived adult epithelium inclu
the Cre recombinase generates the Smad4 null alleles. SMAD4 proteins were undetectab
Cre-mediated recombination was indirectly monitored by expression of EGFP from Rosa
mother, p63 (red) was expressed only in small patches of MDECs lacking EGFP (green)
effectively activated Cre recombinase in vaginal tissues as demonstrated by the express
(red), indicating that SMAD4 is dispensable for maintenance of ΔNp63 expression in thThe activation and the maintenance of ΔNp63 expression are
controlled by different molecular mechanisms
Classic tissue recombination studies have demonstrated that
the differentiation program in adult vaginal epithelium is main-
tained independently of vaginal mesenchymal factors (Cunha,
1976). Thus, adult vaginal epithelium combined with uterine
mesenchyme maintains the expression of p63 (Kurita et al.,
2004). These observations suggest that the transcriptional activity
in the ΔNp63 locus is maintained by a BMP4/ActA-SMAD/RUNX1
independent mechanism. In agreement with this hypothesis,
pSMAD1/5/8 (Fig. 2B) and RUNX1 expressions (Fig. 5A) were
downregulated in K14-positive (fully differentiated) vaginal
epithelial cells. In addition, SMAD4 became undetectable in
vaginal epithelium by P6 (not shown), and Runx1 cKO vaginal
epithelium, which was completely negative for RUNX1, main-
tained expression of p63 in the basal cells (Fig. 5B). To test the
requirement of BMP4/ActA-SMAD/RUNX1 in the expression of
ΔNp63 in adult vaginal epithelium, we developed doxycycline
(Dox)-inducible, Smad4 knockout (Smad4ﬂox/ﬂox; tetO-cre +; Pax8-
rtTA+; RosaTE/wt) mice for MDECs by crossing the Smad4ﬂox/ﬂox
strain with Pax8-rtTA, tetO-cre and RosaTE mice. The RosaTE trans-
gene allowed detection of Cre activation via EGFP expression,
which indirectly indicated the deletion of ﬂoxed Smad4 alleles.
When Smad4 was deleted in fetal/neonatal MDECs by DOX-
administration to the mother throughout gestation and nursing,
the EGFP reporter and p63 were exclusively expressed in the
vaginal epithelium, conﬁrming the essential role of Smad4 in
ΔNp63 expression during vaginal development (Fig. 5A, embryo
DOX). In contrast, when DOX was administered after ΔNp63
expression was established in vaginal epithelium, the deletion of
Smad4 did not affect expression of ΔNp63, as revealed by co-
expression of ΔNp63 and the EGFP reporter (Fig. 5A, adult DOX) in
vaginal epithelial cells. Therefore, SMAD4 is dispensable in main-
taining the expression of ΔNp63 in adult vaginal epithelium.
As we generated ΔNp63 cKO (Trp63Np63-EGFP-KI/ﬂoxN; Pax2-Cre+),
we realized that EGFP was nearly undetectable in the vagina of the
ΔNp63 cKO, suggesting that ΔNp63 was required to maintain the
expression of ΔNp63 itself. To avoid complications caused byfferentiated vaginal epithelial cells. (A) RUNX1 is downregulated in squamous basal
or RUNX1 than K14-negative cells (above the dotted line). (B) RUNX1 is dispensable
, RUNX1 was undetectable in epithelial cells that expressed p63 (red). White arrow
(green) were co-expressed. Thus, RUNX1 is dispensable for expression of ΔNp63 in
In DOX-inducible Smad4 KO mice for MDECs, the reverse tetracycline transactivator
ding VgE. DOX administration induces the expression of the tetO-cre transgene, and
le in the adult vaginal epithelial cells by immunostaining. Therefore, the efﬁcacy of
TE allele. When DOX was administered from embryo to neonate (E1.5-P5) through
expression. A 3 week-treatment of DOX starting at weaning (from P21 to P42) also
ion of EGFP throughout the VgE. However, EGFP-positive basal cells expressed p63
e adult VgE. Bar¼50 mm.
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and heterozygous mice for the ΔNp63-EGFP knock-in allele
(ΔNKI). While heterozygous mice can express both TA and ΔN
isoforms, homozygous mice only express TA forms. In both
genotypes, transcriptional activity of the ΔNp63 locus was mon-
itored by the expression of EGFP from the ΔNKI locus. At E18.5,
EGFP was detected in the MDECs within the vagina and cervix of
heterozygous and homozygous mice (N¼3 each, Fig. 6A E18.5),
indicating that the ΔNp63 locus is equally activated in the
embryonic MDECs irrespective of ΔNp63 expression. The isolated
embryonic vaginae were then transplanted under the subrenal
capsule of NSG mice (Shultz et al., 2005) and grown for 2 weeks to
develop into mature vaginal tissues. While the mature vaginae of
ΔNKI heterozygous mice maintained EGFP expression, the origin-
ally EGFP-positive vaginae of ΔNKI homozygous mice lost EGFPFig. 6. ΔNp63 stabilizes/maintains ΔNp63 expression in differentiated vaginal
epithelium. (A) Activation of ΔNp63 locus is independent of ΔNp63 expression.
In E18.5 urogenital tracts from ΔNKI heterozygous and homozygous mice, EGFP
expression from ΔNKI locus was observed in the ΔNp63 positive epithelial tissues
of the bladder and urethra in both genotypes. In the female reproductive tract,
EGFP was detected in the vagina (outlined with dotted line) and cervix, but not in
the uterus. (B and C) Stabilization of ΔNp63 activity requires ΔNp63 protein.
Isolated vaginal anlages (A, outlined by dotted line) were grown as subrenal grafts
for 2 weeks to develop into mature vaginae. Vaginal grafts of both genotypes grew
equally (B, bright ﬁeld). However, EGFP expression was detected only in the
heterozygous vaginae (B, EGFP) (N¼3 for each genotype). The absence of EGFP
expression in the vaginal epithelium of homozygous mice was conﬁrmed by a more
sensitive immunoﬂuorescence assay (C). While heterozygous vagina demonstrated
normal morphology with EGFP (green) and p63 (red) expression, homozygous
vagina was totally negative for EGFP and p63 (epithelium is outlined).expression after two weeks of in vivo growth, indicating that the
ΔNp63 locus was transcriptionally inactive (Fig. 6B and C). These
observations supported our model that ΔNp63 is required for the
maintenance of its expression through an unidentiﬁed mechan-
ism. Hence, there are two phases in the regulation of ΔNp63
expression in vaginal epithelium: its activation by the BMP4/ActA-
SMAD/RUNX1 signaling pathway and the stabilization of the
activated locus by a ΔNp63-dependent signaling pathway
(Fig. 7). Because the ﬁrst “activation of locus” phase is prerequisite
for the second phase, disruption of the ﬁrst phase by DES
during development permanently affects the vaginal epithelial
differentiation.Discussion
The DES incident is probably the best-documented case of
chemical exposure in human history. The health conditions of DES
daughters in the United States have been closely monitored for
decades (Labarthe et al., 1978). The investigations presented here
focused on the pathogenesis of vaginal adenosis, which shows a
strikingly high incidence among DES daughters. Through a series
of studies utilizing mouse models, we have successfully demon-
strated for the ﬁrst time that cell fate of vaginal epithelium is
induced by BMP4 and ActA via SMAD mediated activation of the
ΔNp63 locus, that the expression of RUNX1 is required for SMAD-
mediated ΔNp63 activation in the cranial portion of the vaginal
epithelium, and that developmental exposure to DES induces
vaginal adenosis by altering epithelial cell fate via a down-
regulation of RUNX1.
This study is particularly important for demonstrating that a
chemical exposure during development can cause precancerous
lesions by inducing metaplasia via an alteration of cell fate. Our
ﬁndings are summarized in Fig. 7. As demonstrated by organ-
culture study, we propose that BMP4 is the main player in
activation of vaginal epithelial cell fate in MDECs and that ActA
plays a supportive role. Recently, Nakajima et al. (2011) proposed
that developmental exposure to DES induces vaginal adenosis by
attenuating Activin-signaling. However, our study focusing on the
fornix at P2-3 could not conﬁrm their observation that DES
reduces the signals for phospho-SMAD2 in neonatal vaginal
epithelium. They also demonstrated that Inhibin blocked expres-
sion of p63 in the organ culture of neonatal vaginae. It should be
noted that Inhibin blocks both ActA and BMP4 signaling (Wiater
and Vale, 2003).
Whether SMADs and RUNX1 form a complex to activate ΔNp63
was not addressed in the current study due to technical difﬁcul-
ties. First, the yield of vaginal epithelium from a P2-3 mouse is
very small. Second, the epithelial tissue is heterogeneous, and
ΔNp63 is expressed only in a subpopulation of epithelial cells.
Third, as clearly shown in the Runx1 cKO study, there is a regional
difference in the function of RUNX1 within vaginal epithelium. The
ECR browser identiﬁed a binding site for the RUNX/core binding
factor β (CBFβ) heterodimer (TGTGGTT) conserved between human
and mouse, ∼500 bp downstream of the Smad binding sites. How
SMADs and RUNX1 cooperate in the differentiation of MDECs is a
subject for future investigation.
In DES daughters, vaginal adenosis is found in the cranial
portion, particularly within the fornix of the vagina. Our previous
study demonstrated that DES disrupts expression of p63 in vaginal
epithelium only in the cranial portion of vagina (Kurita et al.,
2004). These regional differences in the susceptibility to DES-
induced adenosis may be explained by the regional difference in
the role of RUNX1 in ΔNp63 expression. The mammalian RUNX
family of transcription factors consists of three members: RUNX1,
RUNX2 and RUNX3, and all 3 members have been shown to
Fig. 7. Models: Epithelial cell fate decision in developing vagina. (A) Normal development. Mesenchymal BMP4 and ActA instruct undifferentiated MDECs to become vaginal
epithelium by activating transcription of ΔNp63 locus via SMAD/RUNX1-dependent mechanism. The BMP4/ActA action presumably induces chromatin remodeling to make
the ΔNp63 locus accessible to transcriptional machineries. The transcriptional activity of ΔNp63 locus is then maintained/stabilized by a BMP/Activin-SMAD/RUNX-
independent, ΔNp63-dependent mechanism (red arrow). (B) DES-associated vaginal adenosis. DES/ERα (Kurita et al., 2004) downregulates RUNX1, and inhibits activation of
ΔNp63 locus and subsequent vaginal epithelial program. The ΔNp63-negative MDECs differentiate into columnar uterine epithelium within the vagina, forming vaginal
adenosis.
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(Ito and Miyazono, 2003). Since the levels of Runx2 and Runx3
mRNA in developing uteri and vaginae were below the detection
level (GSE44697), the dispensability of RUNX1 in the lower vagina
is unlikely due to the compensation by other RUNX family
members. We hypothesize that RUNX1 facilitates SMADs mediated
ΔNp63 activation by enhancing the recruitment of the chromatin-
remodeling complex to the silent ΔNp63 locus (Lichtinger et al.,
2010). In this context, ΔNp63 activation can be facilitated by other
transcription factors that can recruit chromatin-remodeling com-
plexes in the absence of RUNX1.
Utilizing the ΔNKI mice, we demonstrated that the ΔNp63
locus activated by BMP/Activin-SMAD/RUNX signaling is stabilized
by a ΔNp63 dependent mechanism. Thus, fully differentiated
vaginal epithelial cells maintain ΔNp63 expression independent
of BMP4/ActA-SMAD/RUNX1. However, our study does not reveal
if ΔNp63 self-regulates its expression in the adult vagina. Tran-
scription activity of the ΔNp63 locus in adult vaginal epithelium
may be maintained by ΔNp63. Alternatively, ΔNp63 may be
required only for the stabilization of the locus during the devel-
opment. To answer this question, conditional deletion of ΔNp63 in
adult vaginal epithelium has to be performed.
How DES downregulates RUNX1 in MDECs also remains as the
most important question of our next study. Since the response of
MDECs to DES was uneven within the vagina, the experiment must
be carefully designed to address this question. It should be noted
that DES upregulated RUNX1 in the P3 uterus (Fig. S4), in
agreement with recent report that estrogen induces RUNX1 in
the adult uterine epithelium (Wall et al., 2013). This observation
further emphasizes the importance of tissue microenvironment in
the response of MDECs to DES.
Although some questions still remain, this study has opened
the door to a new era of research on DES-induced malignancy by
deﬁning the cellular and molecular mechanisms through which
DES induces vaginal adenosis. Given that there have been cases of
vaginal adenoses and clear cell adenocarcinomas reported in
women with no history of DES exposure (Laronda et al., 2012),
this study suggests exposure to any compounds that disrupt the
signaling pathway controlling the cell fate decision in vaginal
epithelium could initiate these conditions.Acknowledgments
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